Literature DB >> 30301796

A potential solution for eliminating hypoxia as a cause for radioresistance.

Mark W Dewhirst1.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 30301796      PMCID: PMC6196549          DOI: 10.1073/pnas.1814212115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  23 in total

1.  Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy.

Authors:  Shigeto Ueda; Darren Roblyer; Albert Cerussi; Amanda Durkin; Anais Leproux; Ylenia Santoro; Shanshan Xu; Thomas D O'Sullivan; David Hsiang; Rita Mehta; John Butler; Bruce J Tromberg
Journal:  Cancer Res       Date:  2012-07-09       Impact factor: 12.701

Review 2.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

3.  Theoretical simulation of oxygen transport to tumors by three-dimensional networks of microvessels.

Authors:  T W Secomb; R Hsu; R D Braun; J R Ross; J F Gross; M W Dewhirst
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

4.  Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.

Authors:  B G Wouters; Y M Delahoussaye; J W Evans; G W Birrell; M J Dorie; J Wang; D MacDermed; R K Chiu; J M Brown
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

5.  Simultaneous administration of glucose and hyperoxic gas achieves greater improvement in tumor oxygenation than hyperoxic gas alone.

Authors:  S A Snyder; J L Lanzen; R D Braun; G Rosner; T W Secomb; J Biaglow; D M Brizel; M W Dewhirst
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

Review 6.  The potential role of intrinsic hypoxia markers as prognostic variables in cancer.

Authors:  Eui Jung Moon; David M Brizel; Jen-Tsan Ashley Chi; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2007-08       Impact factor: 8.401

Review 7.  Chemical radiosensitizers for use in radiotherapy.

Authors:  P Wardman
Journal:  Clin Oncol (R Coll Radiol)       Date:  2007-05-02       Impact factor: 4.126

8.  Quantitative optical spectroscopy: a robust tool for direct measurement of breast cancer vascular oxygenation and total hemoglobin content in vivo.

Authors:  J Quincy Brown; Lee G Wilke; Joseph Geradts; Stephanie A Kennedy; Gregory M Palmer; Nirmala Ramanujam
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors.

Authors:  T W Secomb; R Hsu; E T Ong; J F Gross; M W Dewhirst
Journal:  Acta Oncol       Date:  1995       Impact factor: 4.089

10.  Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism.

Authors:  Martin Benej; Xiangqian Hong; Sandip Vibhute; Sabina Scott; Jinghai Wu; Edward Graves; Quynh-Thu Le; Albert C Koong; Amato J Giaccia; Bing Yu; Ching-Shih Chen; Ioanna Papandreou; Nicholas C Denko
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-10       Impact factor: 11.205

View more
  6 in total

Review 1.  Rationale for hypoxia assessment and amelioration for precision therapy and immunotherapy studies.

Authors:  Mark W Dewhirst; Yvonne M Mowery; James B Mitchell; Murali K Cherukuri; Timothy W Secomb
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

2.  Glutamine deficiency in solid tumor cells confers resistance to ribosomal RNA synthesis inhibitors.

Authors:  Melvin Pan; Christiane Zorbas; Maki Sugaya; Kensuke Ishiguro; Miki Kato; Miyuki Nishida; Hai-Feng Zhang; Marco M Candeias; Akimitsu Okamoto; Takamasa Ishikawa; Tomoyoshi Soga; Hiroyuki Aburatani; Juro Sakai; Yoshihiro Matsumura; Tsutomu Suzuki; Christopher G Proud; Denis L J Lafontaine; Tsuyoshi Osawa
Journal:  Nat Commun       Date:  2022-06-28       Impact factor: 17.694

3.  Hypoxia-Activated Prodrug Evofosfamide Treatment in Pancreatic Ductal Adenocarcinoma Xenografts Alters the Tumor Redox Status to Potentiate Radiotherapy.

Authors:  Shun Kishimoto; Jeffrey R Brender; Gadisetti V R Chandramouli; Yu Saida; Kazutoshi Yamamoto; James B Mitchell; Murali C Krishna
Journal:  Antioxid Redox Signal       Date:  2020-09-15       Impact factor: 7.468

Review 4.  Implementation of the Chick Chorioallantoic Membrane (CAM) Model in Radiation Biology and Experimental Radiation Oncology Research.

Authors:  Nicole Dünker; Verena Jendrossek
Journal:  Cancers (Basel)       Date:  2019-10-07       Impact factor: 6.639

Review 5.  The Role of Imaging Biomarkers to Guide Pharmacological Interventions Targeting Tumor Hypoxia.

Authors:  Bernard Gallez
Journal:  Front Pharmacol       Date:  2022-07-15       Impact factor: 5.988

Review 6.  A Review of the Role of Hypoxia in Radioresistance in Cancer Therapy.

Authors:  Wafa Bouleftour; Elise Rowinski; Safa Louati; Sandrine Sotton; Anne-Sophie Wozny; Pablo Moreno-Acosta; Benoite Mery; Claire Rodriguez-Lafrasse; Nicolas Magne
Journal:  Med Sci Monit       Date:  2021-11-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.